UBS Group AG (UBSN)
Mexican Exchange · Mexico · prices in MXN · close of 20 Oct 2026
Key indicators
| Last close | MXN 869.77 |
|---|---|
| 52-week range | 682.00 – 962.51 |
| Return, 1 month / 3 months | −5.7% / −7.4% |
| Return, 1 year / 3 years | +19.2% / +105.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 25 |
| Volatility (1 year) | 31.8% |
| Worst drawdown (1 year) | -17.5% |
| Average daily value traded | 0.16M MXN |
| Dividend yield | 1.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
UBS Group is a Swiss bank based in Zurich that serves wealthy individuals, institutions and companies around the world. Its main activities are wealth management, investment banking and asset management. The wealth business advises private clients on managing their money, the investment bank helps companies raise capital and trade securities, and the asset management arm runs funds and portfolios for institutional investors. It also operates a retail and corporate banking business in Switzerland.
UBS Group AG trades under the code UBSN on the Mexican Exchange in Mexico, with its price quoted in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
UBS Group AG (UBSN) trades on the Mexican Exchange in Mexico. It last closed at MXN 869.77 on 20 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 168 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.2% and over the last three months it fell 7.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 10.0% | ||
| From 52-week high | -9.4% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.4% | ||
| 6-month return | 25.9% | ||
| 12-month return, skipping the last month | 26.3% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.5% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.16M MXN | ||
| Zero-volume days | 86.7% | ||
| Income | 29 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.1% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −5.7% |
| 3 months | −7.4% |
| 6 months | +25.9% |
| 1 year | +19.2% |
| 3 years | +105.7% |
| 5 years | +196.3% |
Signals
| 50-day / 200-day average | 907.71 / 790.55 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Apr 2026 | MXN 9.5156 |
| 15 Apr 2025 | MXN 8.9837 |
| 30 Apr 2024 | MXN 5.9215 |
| 12 Apr 2023 | MXN 5.0055 |
| 12 Apr 2022 | MXN 4.9673 |
| 13 Apr 2021 | MXN 3.7157 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.